You just read:

ProNAi Reports Significant Activity and Ongoing Durable Responses in Relapsed or Refractory Non-Hodgkin's Lymphoma with PNT2258

News provided by

ProNAi Therapeutics Inc.

Dec 05, 2014, 10:00 EST